[Multiple sclerosis--current status of therapy].
The rational drug-treatment of multiple sclerosis on an immunological basis requires an acquaintance with the different forms of the disease course along with an understanding of the underlying pathomechanisms as well as a thorough knowledge of the chances and limitations of such a therapy. Besides some well established treatment regimens other approaches are presented which are currently evaluated in clinical trials and their effects and side effects are discussed.
4-Aminopyridine↗